Search bioRxiv⌕ Search

Biology subjects

Langer, A.

Publications and source records attributed to Langer, A..

3 recordsLinked to original sources

In-Solution Measurements of Binding Kinetics and Thermodynamics by nano Temperature Alteration Kinetics

Binding kinetics are central to mechanism-driven drug discovery. Previously, we established Spectral Shift technology for the measurement of equilibrium binding affinity by detecting small shifts in the emission spectrum of a fluorescently labeled molecule upon binding to a ligand. While slow binding kinetics can be observed as a gradual change toward equilibrium after mixing the binding partners, faster interactions often have already reached equilibrium once the measurement is started. Here, we extend Spectral Shift to the measurement of fast binding kinetics through a method termed "nano Temperature Alteration Kinetics" (nanoTAK). A rapid temperature step perturbs the binding equilibrium of an enthalpically driven interaction, and the subsequent relaxation toward the new equilibrium is monitored in real time by recording the time-dependent Spectral Shift signal. The relaxation directly encodes the association rate kon and dissociation rate koff of the interacting molecules, which are extracted by fitting data of a full ligand dilution series to a global kinetic model. In addition, the fit also returns thermodynamic parameters of the interaction such as the binding enthalpy and entropy. We validate the approach across three tiers of molecular interactions. First, hybridization of a 10-mer DNA duplex serves as a model system with large binding enthalpy. Global fits match the data over three different temperature steps and confirm the accuracy of the derived fit model. Second, the kinase p38 with a set of six ATP-competitive and allosteric inhibitors demonstrates that the method extends to a classical protein-small molecule system with substantially smaller enthalpic changes, yielding consistent rate constants across compounds and temperatures and offering unique insights into their temperature dependence. Third, the degrader system consisting of VHL E3-ligase complex (VCB), PROTAC MZ1 and bromodomain 2 of BRD4 (BRD4(BD2)) illustrates the application to a higher-order system, revealing differences in the binding kinetics between the binary and ternary complex. The presented method can resolve interactions that re-equilibrate faster than within ~1 second, a timescale that can be difficult to access reliably with surface-based instruments. Binding kinetics can be measured both near room temperature, using a temperature step from 20 to 25 {degrees}C, but also, as an inherent feature of the approach, at physiologically relevant temperatures such as 37 {degrees}C.

biophysics↗

Interlaboratory benchmarking of differential scanning fluorimetry reveals sources of variability in protein thermal stability parameters

Differential scanning fluorimetry (DSF) is widely used to assess protein thermal stability and to compare protein variants, ligands, or formulations with limited sample consumption. Yet, the reproducibility of DSF derived parameters across laboratories, instruments and analysis workflows remains poorly defined. Here, we report a two phase interlaboratory benchmark using a shared VHH sample across 26 laboratories, 28 instruments and seven DSF instrument models. In Phase 1, participants applied their routine acquisition and analysis workflows, whereas in Phase 2, acquisition conditions were harmonised. Datasets were analysed locally and then centrally reprocessed with MoltenProt. Participant reported apparent melting temperatures (Tm) showed good within instrument repeatability but moderate inter instrument dispersion. Harmonisation of acquisition conditions did not substantially reduce this dispersion. Conversely, centralised reprocessing narrowed the distribution among retained datasets, indicating contributions from analysis workflows and data acceptance criteria in addition to instrument dependent factors. Comparison with differential scanning calorimetry (DSC) further showed that apparent Tm depended strongly on the fluorescence readout. For this VHH, single wavelength fluorescence at 350 nm showed the closest agreement with the DSC transition temperature, whereas the 350/330 nm ratio and barycentric mean generally yielded higher values. Furthermore, DSF derived apparent unfolding enthalpies were more variable than apparent Tm. Together, these findings show that DSF can be highly repeatable within a defined instrument and workflow, but that quantitative comparability across instruments depends on instrument specific effects, the choice of fluorescence readout and analysis strategy. Improved comparability will require transparent reporting of acquisition and analysis conditions, explicit data quality criteria, and well characterised reference materials to monitor instrument dependent offsets.

biophysics↗

Fast isolation of sub-nanomolar affinity alpaca nanobody against the Spike RBD of SARS-CoV-2 by combining bacterial display and a simple single-step density gradient selection

Despite unprecedented global efforts to rapidly develop SARS-CoV-2 treatments, in order to reduce the burden placed on health systems, the situation remains critical. Effective diagnosis, treatment, and prophylactic measures are urgently required to meet global demand: recombinant antibodies fulfill these requirements and have marked clinical potential. Here, we describe the fast-tracked development of an alpaca Nanobody specific for the receptor-binding-domain (RBD) of the SARS-CoV-2 Spike protein with therapeutic potential applicability. We present a rapid method for nanobody isolation that includes an optimized immunization regimen coupled with VHH library E. coli surface display, which allows single-step selection of high-affinity nanobodies using a simple density gradient centrifugation of the bacterial library. The selected single and monomeric Nanobody, W25, binds to the SARS-CoV-2 S RBD with sub-nanomolar affinity and efficiently competes with ACE-2 receptor binding. Furthermore, W25 potently neutralizes SARS-CoV-2 wild type and the D614G variant with IC50 values in the nanomolar range, demonstrating its potential as antiviral agent.

molecular biology↗